Bio-View Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Daniel Klain

Chief executive officer

₪1.2m

Total compensation

CEO salary percentage77.05%
CEO tenure1.9yrs
CEO ownershipn/a
Management average tenure13.2yrs
Board average tenure2.8yrs

Recent management updates

Shareholders Will Probably Not Have Any Issues With Bio-View Ltd's (TLV:BIOV) CEO Compensation

Dec 04
Shareholders Will Probably Not Have Any Issues With Bio-View Ltd's (TLV:BIOV) CEO Compensation

Recent updates

Some Shareholders Feeling Restless Over Bio-View Ltd's (TLV:BIOV) P/E Ratio

Dec 19
Some Shareholders Feeling Restless Over Bio-View Ltd's (TLV:BIOV) P/E Ratio

Shareholders Will Probably Not Have Any Issues With Bio-View Ltd's (TLV:BIOV) CEO Compensation

Dec 04
Shareholders Will Probably Not Have Any Issues With Bio-View Ltd's (TLV:BIOV) CEO Compensation

Estimating The Intrinsic Value Of Bio-View Ltd (TLV:BIOV)

Feb 14
Estimating The Intrinsic Value Of Bio-View Ltd (TLV:BIOV)

Does BioView Ltd.'s (TLV:BIOV) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

Jan 20
Does BioView Ltd.'s (TLV:BIOV) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

What BioView Ltd.'s (TLV:BIOV) 35% Share Price Gain Is Not Telling You

Nov 29
What BioView Ltd.'s (TLV:BIOV) 35% Share Price Gain Is Not Telling You

CEO Compensation Analysis

How has Daniel Klain's remuneration changed compared to Bio-View's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024₪1m₪947k

-₪3m

Sep 30 2024n/an/a

-₪1m

Jun 30 2024n/an/a

₪887k

Mar 31 2024n/an/a

₪635k

Dec 31 2023₪3m₪1m

₪383k

Compensation vs Market: Daniel's total compensation ($USD367.51K) is about average for companies of similar size in the IL market ($USD440.93K).

Compensation vs Earnings: Daniel's compensation has been consistent with company performance over the past year.


CEO

Daniel Klain (46 yo)

1.9yrs
Tenure
₪1,229,000
Compensation

Mr. Daniel Klain served as President of Bio-View Ltd from 2023 and serves as its CEO since August 14, 2023. Mr. Klain joined the Bio-View Ltd in 2006. Mr. Klain joined BioView in 2006 as a software enginee...


Leadership Team

NamePositionTenureCompensationOwnership
Daniel Klain
Chief Executive Officer1.9yrs₪1.23mno data
Inbal Hillel
Vice President of Operations13.2yrs₪667.00kno data
Elad Kafir
Vice President of Marketing & Sales15yrs₪804.00kno data
Yuval Harari
Deputy Chief Executive Officer16.3yrs₪718.00k0.35%
₪ 90.6k
Liat Bids
Business Development Manager & Director1.9yrs₪364.00kno data
David Kutas
North American Operations Manager18.1yrs₪924.00kno data
Atiya Pine
VP of Finance & CFO1.9yrsno datano data
13.2yrs
Average Tenure
49yo
Average Age

Experienced Management: BIOV's management team is seasoned and experienced (13.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Liat Bids
Business Development Manager & Director2.8yrs₪364.00kno data
Shimon Cohen
Independent External Director2.8yrsno datano data
Yosef Gideonin
Independent External Director2.8yrsno datano data
Shir Razan
Chairman of the Board of Directors2.8yrsno datano data
Gabriel Gimel
Independent External Director2.8yrsno datano data
Hagai Akashia
Director2.2yrsno datano data
2.8yrs
Average Tenure
43yo
Average Age

Experienced Board: BIOV's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/06 04:46
End of Day Share Price 2025/07/03 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bio-View Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.